| 000 | 01599 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517160252.0 | ||
| 264 | 0 | _c20190628 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a0001-5385 | ||
| 024 | 7 |
_a10.1080/00015385.2017.1291187 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Hua | |
| 245 | 0 | 0 |
_aPrognostic value of galectin-3 on admission in Chinese patients with heart failure: a prospective observational study. _h[electronic resource] |
| 260 |
_bActa cardiologica _cApr 2017 |
||
| 300 |
_a188-195 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCause of Death _xtrends |
| 650 | 0 | 4 |
_aChina _xepidemiology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGalectin 3 _xblood |
| 650 | 0 | 4 |
_aHeart Failure _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Admission |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSurvival Rate _xtrends |
| 700 | 1 | _aChen, Qingyong | |
| 700 | 1 | _aLi, Yingying | |
| 700 | 1 | _aJing, Xianchao | |
| 700 | 1 | _aLiang, Tianya | |
| 700 | 1 | _aYang, Jiefu | |
| 773 | 0 |
_tActa cardiologica _gvol. 72 _gno. 2 _gp. 188-195 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/00015385.2017.1291187 _zAvailable from publisher's website |
| 999 |
_c27261559 _d27261559 |
||